Search CCEL
CRYO CELL INTERNATIONAL INC
NYSE · CIK 862692
Last close3.99
Daily change-0.06 (-1.48%)
10 Years gain+42.42%
Dividends TTM0 (-100.00%)
Dividend yield0.00%
Fundamental Analysis
CCEL · STANDARD
SIC 8090 · Services-Misc Health & Allied Services, NEC · Fiscal year end 1130
Fundamental
36.0Momentum
n/aAcceleration
n/aConfidence
70.0Annual Revenue8
Quarterly Revenue26
Annual CFO13
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth8.3 / 25
Quality12.8 / 25
Capital Efficiency0.0 / 20
Balance Sheet3.1 / 15
Shareholder Economics10.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Key Metrics
Revenue Growth TTM6.91%OK
Revenue CAGR 3Y8.04%OK
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y6.46%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Nov 30, 2025 | n/a | $19.08M | $482,394.00 | $5.48M | $5.25M | n/a | n/a | n/a | n/a | 8.07M |
| 2025 FY Nov 30, 2024 | n/a | $23.25M | $3.48M | $6.01M | $3.61M | n/a | n/a | n/a | n/a | 8.21M |
| 2024 FY Nov 30, 2023 | n/a | $6.03M | -$12.30M | $8.92M | $2.08M | n/a | n/a | n/a | -939.73% | 8.34M |
| 2023 FY Nov 30, 2022 | n/a | $19.99M | $4.02M | $8.57M | -$3.60M | n/a | n/a | n/a | 208.19% | 8.48M |
| 2022 FY Nov 30, 2021 | n/a | $18.68M | $4.02M | $7.93M | $6.09M | n/a | n/a | n/a | n/a | 8.36M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $25.89M | sum latest 4 fiscal quarters Revenue | OK | 0001193125-18-218864, 0001193125-17-310883 |
| Revenue Growth TTM | 6.91% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-18-218864, 0001193125-17-310883 |
| Revenue CAGR 3Y | 8.04% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-18-064199 |
| Revenue CAGR 5Y | 7.15% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-18-064199 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-18-218864 |
| Current Ratio | 1.02x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0x | (Cash + Short-term Investments) / Total Debt | OK | derived |
| Revenue per Diluted Share | $3.27 | Revenue / Diluted Shares | OK | 0001193125-18-218864, 0001193125-17-310883 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | derived |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | 0001193125-18-218864 |